Lung cancer trials in Costa Rica

3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  Where

  San José

  Age

  18 years and over

  People

  348 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06345729 · EU 2023-507776-42-00
• Phase 3Taking people
  A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

  Where

  San José, San José Capital, Santa Ana

  Age

  18 years and over

  People

  830 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06868277 · EU 2024-517780-24-00
• No phaseNot yet taking people in Costa Rica
  Lung Cancer Screening for Early Detection of Suspicious Lung Nodules in Latin America(LUCAS-LATAM)

  Where

  San José

  Age

  50 years and over

  People

  2,000 worldwide

  Run by

  Latin American Consortium for the Lung Cancer Research

  See details and how to joinNCT07524803